API
In view of its growing exposure in formulations and generics, Elder made a proactive backward integration into the manufacture of APIs with the objective to control quality at all stages, strengthen logistics management and reduce costs.

This integration has helped the company extend its value chain in its formulations driven business model and emerge increasingly competitive. Besides, these, API products are not only intended for captive use but marketed to other users so that it emegges as an independent profit center. Over a peroid of time, the company expects to build on its API competencies and manufacture generic formulations for the regulated markets.

Elder commissioned an Active Pharmaceutical Ingredient plant at Patalganga (Maharashtra) in line with USFDA requirments. Over the years, Elder has been amnufacturing APIs like anti-bacterial, anti-hypertension, anti-diabetic and anti-epiletic therapeutic segments, substituting high cost imported raw materials.

In line with its growing products and therapeutic focus, what was once intended for captive availability now expects to extend to the supply of APIs to international pharma major looking for cost and high quality solutions.

Research & Development : Elder Pharmaceuticals also offers customized products on basis of advanced chemical synthesis capabilities.

Custom Synthesis : Elder Pharmaceuticals also offers customized products on basis of advanced chemical synthesis capabilities.